We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DKS icon
2951
Dick's Sporting Goods
DKS
$19.2B
$317K ﹤0.01%
9,160
+2,508
+38% +$91.8K
NAT icon
2952
Nordic American Tanker
NAT
$1.33B
$317K ﹤0.01%
135,524
-20,370
-13% -$43.9K
HYB
2953
DELISTED
New America High Income Fund, Inc.
HYB
$316K ﹤0.01%
35,624
+3,608
+11% +$31.2K
HEQ
2954
John Hancock Hedged Equity & Income Fund
HEQ
$141M
$315K ﹤0.01%
22,351
-524
-2% -$7.48K
QNST icon
2955
QuinStreet
QNST
$1.26B
$315K ﹤0.01%
19,880
-4,986
-20% -$74.4K
SCPL
2956
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$315K ﹤0.01%
+22,965
New +$340K
ILF icon
2957
iShares Latin America 40 ETF
ILF
$3.81B
$314K ﹤0.01%
9,302
-11,451
-55% -$378K
AMRX icon
2958
Amneal Pharmaceuticals
AMRX
$5.71B
$313K ﹤0.01%
43,693
+5,799
+15% +$59.3K
DHC
2959
Diversified Healthcare Trust
DHC
$2.04B
$313K ﹤0.01%
37,873
-1,162
-3% -$9.68K
FRBA icon
2960
First Bank
FRBA
$452M
$313K ﹤0.01%
26,663
+8,423
+46% +$95.7K
GUT
2961
Gabelli Utility Trust
GUT
$573M
$313K ﹤0.01%
45,943
-2,351
-5% -$15.9K
FISI icon
2962
Financial Institutions
FISI
$814M
$312K ﹤0.01%
10,693
+64
+0.6% +$1.78K
PGEN icon
2963
Precigen
PGEN
$2.51B
$312K ﹤0.01%
40,704
-3,095
-7% -$16.7K
MITK icon
2964
Mitek Systems
MITK
$837M
$311K ﹤0.01%
31,244
-6,068
-16% -$64.7K
DCUE
2965
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
$311K ﹤0.01%
+3,000
New +$311K
CMD
2966
DELISTED
Cantel Medical Corporation
CMD
$311K ﹤0.01%
3,851
+486
+14% +$34.2K
HD icon
2967
CALL
Home Depot
HD
$350B
$310K ﹤0.01%
81,800
+12,700
+18% +$2.53M
PFS icon
2968
Provident Financial Services
PFS
$3.17B
$310K ﹤0.01%
12,777
+1,066
+9% +$27K
BSCR icon
2969
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
$309K ﹤0.01%
+15,048
New +$301K
LTS
2970
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$309K ﹤0.01%
90,030
-26,299
-23% -$90.9K
VYGR icon
2971
Voyager Therapeutics
VYGR
$195M
$308K ﹤0.01%
11,328
-4,187
-27% -$95.8K
INSI
2972
DELISTED
Insight Select Income Fund
INSI
$308K ﹤0.01%
15,279
-47
-0.3% -$897
KOP icon
2973
Koppers
KOP
$956M
$307K ﹤0.01%
10,457
-1,089
-9% -$30.3K
XLRN
2974
DELISTED
Acceleron Pharma
XLRN
$306K ﹤0.01%
7,455
-1,843
-20% -$76.3K
OMF icon
2975
OneMain Financial
OMF
$7.27B
$305K ﹤0.01%
9,022
+2,600
+40% +$84.9K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.